CEO Paul Brennan said, “To have surgeons of this calibre presenting such a wide variety of clinical applications demonstrates the robust nature of NovoSorb BTM compared with biologic products. We have significant opportunities before us in the market place and the presentations underline our sales push in the US”
- Forums
- ASX - By Stock
- PNV
- Ann: First US Surgeon Podium presentations of Novosorb BTM
Ann: First US Surgeon Podium presentations of Novosorb BTM, page-4
-
- There are more pages in this discussion • 23 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PNV (ASX) to my watchlist
(20min delay)
|
|||||
Last
$2.29 |
Change
-0.010(0.43%) |
Mkt cap ! $1.580B |
Open | High | Low | Value | Volume |
$2.33 | $2.34 | $2.24 | $2.151M | 944.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 9090 | $2.27 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$2.29 | 15253 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 2193 | 2.270 |
5 | 17358 | 2.260 |
2 | 7860 | 2.250 |
4 | 13142 | 2.240 |
7 | 120207 | 2.230 |
Price($) | Vol. | No. |
---|---|---|
2.290 | 7621 | 3 |
2.300 | 14557 | 6 |
2.310 | 2136 | 1 |
2.320 | 6496 | 2 |
2.330 | 13092 | 4 |
Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
Featured News
PNV (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online